CLINICAL_TRIALS
trial_result
· 2017-01-30
Clinical Trial Update: A One Year Trial Evaluating the Safety and Efficacy of the ALK House Dust Mite Allergy Tablet [Phase 3]
Summary
A Phase 3 trial evaluating the safety and efficacy of the ALK House Dust Mite Allergy Tablet has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ALK-Abelló A/S | Conditions: House Dust Mite Allergy | Phase 3 | Status: COMPLETED